For generations, a condition affecting one in eight women has been understood almost entirely through the language of fertility — irregular cycles, unwanted hair, the hope or loss of pregnancy. New research now asks medicine to look further, and what it finds is sobering: women with Polycystic Ovary Syndrome carry roughly double the risk of heart attack and stroke, a burden that persists independent of weight and accumulates quietly across a lifetime. The heart, it turns out, has always been part of this story.
Study links PCOS to elevated heart disease risk in women
Women with PCOS face elevated mortality risk from heart attacks and strokes, with cardiovascular disease responsible for 30% of annual deaths in women globally.
PCOS isn't just a fertility problem—it's a lifelong metabolic threat to the heart
Mark
Why has PCOS been so misunderstood for so long?
Mimi
Because the name itself pointed everyone toward the ovaries and reproduction. Women came to their doctors with irregular periods or trouble getting pregnant, and that became the entire frame. Nobody was asking what else was happening in the body—the insulin resistance, the inflammation, the slow accumulation of cardiovascular damage.
Mark
But surely doctors knew about the metabolic side effects?
Mimi
They knew about them in isolation. A woman might be told she has high blood pressure, or that her cholesterol is off, or that she's at risk for diabetes. Each problem got treated separately. Nobody was connecting the dots and saying: this is all one condition, and it's attacking your heart.
Mark
What changes with the new UK guidance?
Mimi
It shifts the entire conversation. Instead of asking "Can you have children?" the question becomes "What is this condition doing to your cardiovascular system over the next 30 years?" Regular screening means catching problems early, before they become a heart attack.
Mark
Does the risk go away after menopause?
Mimi
That's the point—it doesn't. PCOS is a metabolic disorder, not a reproductive one. The ovaries may stop cycling, but the insulin resistance, the inflammation, the damage to blood vessels—all of that continues. That's why the new name, PMOS, matters. It's not about the ovaries anymore. It's about the whole system.
Mark
So a woman with PCOS needs to think of herself as someone with a chronic heart condition?
Mimi
Not exactly a heart condition yet, but someone at substantially elevated risk of developing one. The difference is that risk can be modified. Early screening, metabolic management, lifestyle changes—these things matter. But only if the condition is recognized for what it actually is.
Le Pouls
- Cardiovascular disease already claims nearly a third of all female deaths globally each year — and new research reveals PCOS is silently amplifying that toll for one in eight women of reproductive age.
- The doubled risk of heart attack and stroke in women with PCOS holds even after accounting for obesity, meaning the syndrome itself — through insulin resistance, chronic inflammation, and metabolic dysfunction — is directly injuring the heart.
- For decades, PCOS has been managed as a fertility issue, leaving the metabolic damage it causes to accumulate undetected in the background of women's medical histories.
- UK health authorities have now moved to close that gap, mandating regular cardiovascular and metabolic screening for PCOS patients — a formal acknowledgment that this condition does not end when childbearing does.
- The trajectory points toward a necessary reframing: PCOS is a lifelong metabolic disorder, and heart health monitoring must begin at diagnosis, not decades later when damage has already been done.
For generations, a condition affecting one in eight women has been understood almost entirely through the language of fertility — irregular cycles, unwanted hair, the hope or loss of pregnancy. New research now asks medicine to look further, and what it finds is sobering: women with Polycystic Ovary Syndrome carry roughly double the risk of heart attack and stroke, a burden that persists independent of weight and accumulates quietly across a lifetime. The heart, it turns out, has always been part of this story.
Heart disease is the leading killer of women worldwide, responsible for nearly a third of all female deaths each year — a toll that outpaces cancer by a factor of two. It strikes across age groups, and women who survive a heart attack are statistically more likely to die from it than men are. Against this backdrop, a growing body of research has identified PCOS as one of the condition's most underrecognized drivers.
Polycystic Ovary Syndrome — recently renamed Polyendocrine Metabolic Ovarian Syndrome to better reflect its systemic reach — affects roughly one in eight women of reproductive age. It has long been framed as a reproductive condition: irregular periods, acne, unwanted hair growth, weight gain. But that framing, researchers now argue, has obscured something far more dangerous. Women with PCOS are approximately twice as likely to suffer a heart attack or stroke as women without it, and this elevated risk holds even when obesity is removed from the equation.
The mechanism is metabolic. PCOS frequently produces insulin resistance, which raises blood sugar, increases the risk of type 2 diabetes, and triggers chronic inflammation throughout the body — all established pathways to cardiovascular disease. When combined with the higher rates of high blood pressure, abnormal cholesterol, and metabolic syndrome that accompany the condition, the cumulative damage to blood vessels over time becomes significant.
The deeper problem, health experts say, is that PCOS has been treated as a cluster of separate symptoms rather than an integrated disorder with long-term consequences. Women and their physicians focus on managing cycles or pursuing fertility, while the metabolic complications accumulate silently in the background. A PCOS diagnosis too often becomes a footnote rather than a flag.
New UK guidance now calls for regular screening that extends well beyond reproductive health — tracking diabetes risk, cardiovascular markers, and metabolic complications across a woman's entire life. The message is a direct challenge to how the condition has been understood: PCOS does not resolve after childbearing. It is a lifelong condition, and the heart has always been part of what it threatens.
Heart disease kills more women than any other condition—and women who survive a heart attack are more likely to die from it than men are. Cardiovascular disease accounts for nearly a third of all female deaths each year, a toll that dwarfs cancer by a factor of two. The disease respects no age boundary; it can strike a woman at any point in her life.
A new body of research has identified one hormonal condition as a significant driver of this cardiovascular burden in women. Polycystic Ovary Syndrome, or PCOS—recently renamed Polyendocrine Metabolic Ovarian Syndrome to better capture its systemic nature—affects roughly one in eight women of reproductive age, making it one of the most prevalent endocrine disorders in the population. The condition has long been understood primarily through the lens of fertility and reproduction: irregular or absent periods, acne, unwanted hair growth, scalp thinning, weight gain, and the ovarian cysts that gave the syndrome its original name. But the emerging research suggests this framing has obscured a far more serious threat.
Women with PCOS face roughly double the risk of heart attack and stroke compared to women without the condition. This elevated risk persists even when researchers account for obesity and other conventional cardiovascular risk factors, indicating that the syndrome itself—not merely its associated weight gain—directly damages heart health. The mechanism is rooted in metabolism. Many women with PCOS develop insulin resistance, a state in which the body's cells fail to respond properly to insulin. Blood sugar rises. The risk of type 2 diabetes climbs. Chronic inflammation spreads through the body. These three factors alone are known drivers of cardiovascular disease. Layer on top of that the higher rates of obesity, high blood pressure, abnormal cholesterol, and metabolic syndrome that accompany PCOS, and the cumulative damage to blood vessels becomes substantial.
The problem, according to health experts, is that PCOS has been treated as a collection of separate symptoms rather than as an integrated metabolic disorder with long-term consequences. Women and their doctors focus on managing irregular periods or addressing fertility concerns, missing the opportunity to identify and treat the metabolic complications that accumulate silently over years. A diagnosis of PCOS often becomes a footnote in a woman's medical history rather than a flag for sustained cardiovascular monitoring.
New guidance from the United Kingdom now recommends that women with PCOS receive regular health screenings that extend well beyond reproductive concerns. These checks should track not only the risk of diabetes but also the markers of heart disease and other metabolic complications that may not announce themselves with obvious symptoms. The shift reflects a growing consensus among physicians: PCOS is not a fertility problem that resolves after childbearing years. It is a lifelong metabolic condition that demands attention to heart health from diagnosis onward.
Citations marquantes
PCOS isn't just a reproductive issue; it's a long-term metabolic problem that needs real attention, even after the childbearing years— Health experts cited in the research
Envie de l'histoire complète ?
Lire l'original sur The Times of India ↗
Health & Medicine